Loading…
Beta Drugs (BETA)₹1,882+3.44%Pharmaceuticals
At the end of the Sep 2026 quarter, Beta Drugs' shareholders were: promoters 58.87%, FIIs 1.38%, DIIs 6.43%, public 33.32%. Promoter holding is down 0.19 percentage points from 59.06% a quarter earlier. FII holding is up 0.48 percentage points from 0.90% a year earlier. 0.00% of promoter shares were pledged. It had 10,150 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.69% | 66.69% | 66.69% | 66.69% | 66.69% | 66.69% | 66.69% | 66.69% | 64.86% | 64.59% | 59.06% | 58.87% |
| FIIs | 0.32% | 0.32% | 0.90% | 1.17% | 1.16% | 0.90% | 0.90% | 0.90% | 1.15% | 1.17% | 1.03% | 1.38% |
| DIIs | 0.02% | 0.06% | 0.12% | 0.16% | 0.17% | 0.17% | 0.26% | 0.29% | 1.89% | 2.14% | 6.21% | 6.43% |
| Public | 32.97% | 32.93% | 32.29% | 31.98% | 31.98% | 32.24% | 32.15% | 32.12% | 32.10% | 32.10% | 33.70% | 33.32% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 1,929 | 2,117 | 2,324 | 2,568 | 2,883 | 3,055 | 3,140 | 3,185 | 3,696 | 4,738 | 7,362 | 10,150 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Neeraj Batra | Promoter | 58.26% | −0.19 |
| Suryavanshi Commotrade Private Limited | Public | 6.07% | −0.02 |
| Ashish Kacholia | Public | 4.42% | −0.48 |
| Healthquad Trust Ii | DII | 4.29% | +0.19 |
| Inti Capital Vcc - Inti Capital I | Public | 2.01% | +0.09 |
| Airavat Capital Trust - Airavat Capital Trust Ii | DII | 1.58% | −0.01 |
| Bsas Infotech Limited | Public | 1.20% | −0.01 |
| Anjali Ajit Deval | Public | 1.12% | 0.00 |
| Onkar Singh | Public | 1.00% | New |
| Rahul Batra | Promoter | 0.37% | −0.01 |
| Varun Batra | Promoter | 0.31% | 0.00 |
| Aditi Batra | Promoter | 0.01% | 0.00 |
| Heena Batra | Promoter | 0.01% | 0.00 |
| NBFCs registered with RBI | DII | 0.01% | 0.00 |
Promoters held 58.87% of Beta Drugs at the end of the Sep 2026 quarter, down 7.82 percentage points from 66.69% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 1.38% (up 0.35 percentage points from 1.03% a quarter earlier) and domestic institutions (DIIs) held 6.43% (up 0.22 percentage points from 6.21% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Beta Drugs had 10,150 shareholders at the end of the Sep 2026 quarter, against 3,185 a year earlier.
Suryavanshi Commotrade Private Limited (Public) held 6.07% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.